Immuno-oncology (IO) expertise at Nexelis, a Q² Solutions Company, is founded on our immense depth of experience in assay development. IO encompasses a great deal, but at its heart is an immune response. Immunogenicity is a Nexelis core competency.
In immuno-oncology, Nexelis continues to expand our service offering. Preclinical and clinical exploratory solutions are available globally, supported by teams with decades of experience to provide scientific and technical solutions using a multiplatform approach to support your clinical investigation in oncology.
With our flexible and custom programs, we stay at the cutting edge of scientific excellence in IO. Nexelis brings speed and improved decision-making to your development program. Similarly, your scientific and project management points of contact remain consistent for the project duration. We commit to providing exceptional service to improve the success of your program.